Table 4 Changes in serum lipid biochemistry profiles after placebo and OPP treatments (Mean ± SD).
Parameter | Intervention day | Placebo | 250 mg/d OPP | 1000 mg/d OPP | 1500 mg/d OPP | p# |
|---|---|---|---|---|---|---|
TC (mmol/L) | Day-1 | 4.66 ± 0.73 | 4.50 ± 0.63 | 4.47 ± 0.76 | 4.51 ± 0.65 | 0.956 |
Day-30 | 4.73 ± 0.73 | 4.49 ± 0.65 | 4.74 ± 0.85 | 4.57 ± 0.62 | ||
Day-60 | 4.66 ± 0.84 | 4.75 ± 0.64b | 4.76 ± 0.85a | 4.88 ± 0.69b | ||
p* | 0.777 | 0.007 | 0.015 | < 0.001 | ||
HDL-C (mmol/L) | Day-1 | 1.46 ± 0.33 | 1.39 ± 0.29 | 1.43 ± 0.35 | 1.40 ± 0.24 | 0.565 |
Day-30 | 1.38 ± 0.34 | 1.33 ± 0.28 | 1.46 ± 0.35 | 1.35 ± 0.24 | ||
Day-60 | 1.38 ± 0.33a | 1.36 ± 0.29 | 1.50 ± 0.36 | 1.35 ± 0.26 | ||
p* | 0.029 | 0.170 | 0.420 | 0.190 | ||
LDL-C (mmol/L) | Day-1 | 2.81 ± 0.64 | 2.72 ± 0.51 | 2.69 ± 0.68 | 2.74 ± 0.57 | 0.977 |
Day-30 | 2.97 ± 0.70 | 2.78 ± 0.59 | 2.93 ± 0.75a | 2.78 ± 0.49 | ||
Day-60 | 2.83 ± 0.73 | 2.92 ± 0.50 | 2.87 ± 0.74 | 3.05 ± 0.56b | ||
p* | 0.295 | 0.061 | 0.046 | 0.003 | ||
TG (mmol/L) | Day-1 | 0.86 ± 0.41 | 0.85 ± 0.49 | 0.76 ± 0.32 | 0.83 ± 0.29 | 0.408 |
Day-30 | 0.87 ± 0.37 | 0.85 ± 0.34 | 0.78 ± 0.37 | 1.04 ± 0.61 | ||
Day-60 | 0.98 ± 0.43 | 1.06 ± 0.58b | 0.89 ± 0.50 | 1.15 ± 0.85 | ||
p* | 0.052 | 0.013 | 0.144 | 0.072 |